26
DAFTAR PUSTAKA
Am Fam Physician. 2004. Nail Abnormalities Clues to Systemic Disease.
Available from
19 Mei 2014]
Agarwaal, Rajeev MD. 2014. Assessment and Management of Hypertension in
Patients on Dialysis. Available from:
early/2014/04/02/ASN.2013060601.full
Agarwaal, Rajeev MD. 2003. Prevalence, treatment, and control of hypertension
in chronic hemodialysis patients in the United States. Available
from:
[Accessed 23 September 2015]
2015]
Agrawal SK, Pandhi D. Idiopathic half-half nail. Indian J Dermatol. 2005;50:170.
Arora, Pradeep MD. 2014. Chronic Kidney Disease. Available
from:
15 Mei 2014]
Baran B. 1992. Nail Disorders. Medicine International; 102; 4309.
Beheshti, Akram MD. 2013. Dermatological Manifestations Among Patients on
Maintenance Hemodialysis. Available
from:
2014]
Dyachenko P. 2007. Nail Disorders in patients with chronic renal failure and
undergoing haemodialysis treatment: a case control study. J Eur Acad
Dermatol Venereol. 2007;23:340-4
Gregoriou S et al. 2008. Naildisorders and systemic disease: What the nails tell
us. JFP 2008; 57(8)
27
Martinez MA. 2010. Nail disorders in patients with chronic renal failure
undergoing hemodialysis. Avalaible from :
Mill, Durford. 2014. CKD Stages. Avalaible
from:
[Accessed
14 April 2014]
Neumeister, Michael MD. 2012. Nail Pathology. Available from
:
Mei 2014]
Phillips, Benjamin Z MD. 2013. Nail Anatomy. Available from
:
Mei 2014]
Purwanto, Bambang. 2010. Gagal Ginjal Akut dan Kronis.Divisi Ginjal &
Hipertensi SMF Lab.Ilmu Penyakit Dalam FK.UNS RSUD Dr.Moewardi
Surakarta
Robinson-Boston L, DiGiovanna JJ. 2000. Cutaneous Manifestations of end-stage
renal desease. J Am Acad Dermatol. 2000;43:975-86
Saray Y. 2004. Nail disorders in hemodialysis patients and renal transplant
recipients: a case-control study. J Am Acad Dermatol. 2004;50:197-202
Sudoyo, Aru W. 2009. Buku Ajar Ilmu Penyakit Dalam Jilid II. 5th ed. Jakarta :
Interna Publishing. pp: 1035-1040
Williams, Mark E. MD. 2014. Examining the Fingernail. Available from
Zaiac MN. 2002. Nails in systemic disease Dermatologic Therapy;15 (2); 99-106